The joint development of a first-of-its-kind suite of artificial intelligence (AI) tax analysis tools for the UK has been announced by KPMG UK and Blue J.
Taft Stettinius & Hollister LLP and Blue J are announcing their partnership to simplify and ameliorate the diagram-making process.
Traditional diagramming tools are costing law firms hours in non-billable work each month. Discover 6 of the biggest issues and their impact.
Attorneys are leveraging tools that simplifying drawing and visualization, maximizing their time. Visual client communication is proving to be a major...
We leverage AI in Blue J Predicts to analyze economic substance arguments in Chemoil's ongoing litigation over tax credits and unprofitable ventures.
The Future of Tax. See how KPMG and Blue J are working together to support the work of tax practitioners everywhere. Learn more
Discover the 5 advantages of intelligent diagramming to drive efficiency and revenue growth for your modern law firm. Download the white paper now.
We analyze a favorable decision for taxpayers who are partners in a partnership trying to profit from the tax credits created by Congress.
Whether you are working on mergers and acquisitions or asset arrangements to optimize tax scenarios, professional diagrams are valuable communication tools.
Type “D” Reorganizations with helpful tips & standard and Rev. Rul. 70-240 diagrams. Non-divisive “D” reorgs are the focus. IRC § 368(a)(1)(D) also discussed.
This infographic guide serves as a reference to the common corporate diagram shapes and conventions that exist, and when they would be used.
With Blue J Folios, find structure charts, IRS guidance, cases, relevant statutes, and more on a number of legal topics - with a click.
Look at the five strategies you can adopt today to build client-ready diagrams faster (and better) than ever before. Reduce hours of work to minutes
For students in the area of tax law, poring over tax code, regulations, and IRS guidance and keeping up with changing laws may not be a thrilling prospect.
This month in our Blue J Predicts column we examine the deduction of legal and litigation expenses in the context of the generic drug industry.
Sign up for the Blue J newsletter today.
Whether you have questions or are interested in booking a demo, we would love to hear from you.